Register entry
- Registered sites
- 1
- Active NDC listings
- 29
- Labeller names
- 6
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Elysium Pharmaceuticals LtdRegistrant: ELYSIUM PHARMACEUTICALS LIMITED | 253 to 256 and 258, Post: Dabhasa Taluka: Padra, Vadodara, Gujarat 391440, India (IND) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3005183272863182240 |
Catalogue
Drug listings by form and route
2929 active NDC listings: 24 human otc drug, 4 drug for further processing, 1 human prescription drug. By marketing category: DRUG FOR FURTHER PROCESSING 28, OTC MONOGRAPH DRUG 1.
| Dosage form | NDCs |
|---|---|
| tablet | 13 |
| capsule, liquid filled | 8 |
| capsule | 3 |
| tablet, film coated | 2 |
| lotion | 1 |
| tablet, delayed release | 1 |
| tablet, for solution | 1 |
| Route | NDCs |
|---|---|
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| elysium pharmaceuticals ltd. | 9 |
| elysium pharmaceuticals ltd | 8 |
| elysium pharmaceuticals limited | 4 |
| elysium pharmaceuticals limited | 4 |
| elysium pharmaceutical ltd | 3 |
| elysium consumer healthcare llc | 1 |
Catalogue
Marketed products
29| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE | capsule, liquid filled | 14803-907DRUG FOR FURTHER PROCESSING |
| - | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | capsule, liquid filled | 14803-909DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet | 14803-013DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet | 14803-281DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen ,Dextromethorphan Hydrobromide, Doxylamine succinate | capsule | 14803-902DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen 325mg, Guaifenesin 200mg, Dextromethorphan HBr 10mg, Phenylephrine HCl 5 mg | capsule, liquid filled | 14803-913DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Diphenhydramine Hydrochloride | tablet | 14803-282DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | capsule, liquid filled | 14803-046DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate | capsule, liquid filled | 14803-047DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Diphenhydramine Hydrochloride | tablet | 14803-174DRUG FOR FURTHER PROCESSING |
| - | Aspirin | tablet, delayed release | 14803-206DRUG FOR FURTHER PROCESSING |
| - | Dextromethorphan Hydrobromide Capsules | capsule, liquid filled | 14803-904DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule | 14803-903DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride 25 | capsule | 14803-912DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine hydrochloride | tablet, film coated | 14803-273DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine hydrochloride (Blue) | tablet, film coated | 14803-302DRUG FOR FURTHER PROCESSING |
| - | Folic Acid | tablet | 14803-516DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin | tablet | 14803-162DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin and dextromethorphan HBR | tablet | 14803-306DRUG FOR FURTHER PROCESSING |
| - | Phenylephrine Hydrochloride | tablet | 14803-003DRUG FOR FURTHER PROCESSING |
| Purpose Dual Treatment SPF 10 | Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3% | lotion, topical | 87033-2000OTC MONOGRAPH DRUG |
| - | Sennosides Tablets 8.6 | tablet | 14803-305DRUG FOR FURTHER PROCESSING |
| - | Sennosides and Docusate sodium | tablet | 14803-301DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, liquid filled | 14803-911DRUG FOR FURTHER PROCESSING |
| - | Simethicone 180 | capsule, liquid filled | 14803-910DRUG FOR FURTHER PROCESSING |
| - | acetaminophen aspirin and caffeine | tablet | 14803-135DRUG FOR FURTHER PROCESSING |
| - | acetaminophen pyrilamine maleate and caffeine | tablet | 14803-118DRUG FOR FURTHER PROCESSING |
| - | acetaminophenand caffeine | tablet | 14803-151DRUG FOR FURTHER PROCESSING |
| - | sodium chloride | tablet, for solution | 14803-304DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- Alembic Pharmaceuticals LimitedVADODARA, IND; Vadodara, IND · 4 sites
- BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITEDVadodara, IND · 3 sites
- Zydus Lifesciences LimitedVadodara, IND · 2 sites
- FARMSON BASIC DRUGS PRIVATE LIMITEDVadodara, IND · 2 sites
- KLM Laboratories Private LimitedVadodara, IND · 2 sites
- Lupin LimitedVadodara, IND
- Sun Pharmaceutical Industries LimitedVadodara, IND
- Ipca Laboratories LimitedVadodara, IND
- Apicore US LLCVadodara, IND
- Kumar Organic Products LimitedVadodara, IND
- USV Private LimitedVadodara, IND
- Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)Vadodara, IND
Compare
Comparable companies in India
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Somerset Therapeutics Private Limited1 site · 187 NDC
- Bionpharma Inc.1 site · 181 NDC
- Jubilant Biosys Limited1 site · 94 NDC
- Xiromed LLC1 site · 94 NDC
- CAPLIN STERILES LIMITED1 site · 88 NDC
- Maithri Drugs Private Limited1 site · 80 NDC
- MSN Pharmachem Private Limited1 site · 54 NDC
- UMEDICA LABORATORIES PRIVATE LIMITED1 site · 52 NDC
- APOTHECON PHARMACEUTICALS PRIVATE LIMITED1 site · 38 NDC
Enquiry
Common questions
- Is ELYSIUM PHARMACEUTICALS LIMITED FDA approved?
- ELYSIUM PHARMACEUTICALS LIMITED holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are ELYSIUM PHARMACEUTICALS LIMITED's drugs manufactured?
- The FDA register lists Vadodara. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does ELYSIUM PHARMACEUTICALS LIMITED make?
- 29 products are listed under ELYSIUM PHARMACEUTICALS LIMITED in the openFDA NDC Directory, most often as tablet; capsule, liquid filled; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.